A New Clinical Trial for a Novel Brain Injury Biomarker
Medicortex Finland Oy (www.medicortex.fi), a biotechnology company developing a diagnostic kit for brain injury based on a medical breakthrough biomarker, recently was granted clearance to begin a multi-center clinical trial. The trial will consist of patients that are admitted to emergency rooms due to a head injury.
View full press release